Leading Excellence
Our Team
Dr. Ramadas Chavakula, Ph.D.
Vice President – Research & Development (Regulated, Domestic & ROW)
Dr. Ramadas Chavakula brings over 30 years of experience in pharmaceutical research and development. He has held key positions at leading organizations including Aurobindo Pharma, Matrix (Mylan) Laboratories, Tyche Industries, Sai Life Sciences, and Neuland Laboratories.
A seasoned R&D leader, Dr. Chavakula has successfully managed end-to-end product development — from process design to regulatory approvals — and is known for his strategic vision, innovation-driven approach, and collaborative leadership.
He has published over 60 research papers in reputable journals and guided 10 PhD scholars. At Tikvah Pharma, he leads R&D initiatives aimed at advancing innovation and global excellence.
Dr. Penke Vijaya Babu, Ph.D.
Director – Advisory Research & Development
Dr. Penke Vijaya Babu brings over 17 years of expertise in pharmaceutical research, process development, and innovation. His experience spans leading roles at Piramal Pharma, Curia India, along with postdoctoral research in Israel & Poland.
Dr. Vijay has contributed to over 250 peer-reviewed publications, authored 38 research papers, holds 6 patents, and has written a book in the field of medicinal and process chemistry. He also serves as a board member, editorial reviewer, and lifetime member of more than 20 scientific organisations and professional societies.
At Tikvah Pharma, he serves as an advisory member for R&D excellence, technology advancement, and innovation in CRO & CDMO process chemistry.
Dr. Pavani Gonnabathula, Ph.D.
Advisory Board Member – Clinical Pharmacology & Regulatory Science
Dr. Pavani is a pharmacology and regulatory science expert with over eight years of experience across academia, government, and industry. Currently a PBPK/PKPD Modelling Scientist at the University of Kentucky, she leads mechanistic and population-based modelling to optimise dosing and support drug development.
Her prior fellowships at the U.S. FDA and CDC advanced Model-Informed Drug Development (MIDD) for antivirals and toxicants, complemented by early R&D experience at Aurobindo Pharma.
At Tikvah Pharma Solutions, she advises on pharmaceutical development, process optimization, and regulatory strategy—strengthening the company’s innovation, quality, and global competitiveness.
R&D Activities, you can take advantage of our rich pool of research experience.
Route & Process Development
We improve troublesome procedures, and identify the best route for manufacture at scale.
Route Design and Synthesis
Novel analogues of lead molecules for optimization studies
Our facility situated on a 10,000 Sq Ft and is highly resilient for operations
Multi-purpose GMP compliance
We have multi-purpose GMP compliance GL reactors capacity of 500 ltr. Which is divided into 100 ltr & 200 ltr.
Hoods & Auto claves
24 inches Centrifuge machine(GMP), 24 trays air Dryer(GMP) and 6 fume Hoods. Auto claves capacity is of 10L, 2L, 100 ML. (Pressure up to 100 bar & Temperature up to 300 °C)
Expert knowledge and adaptation of new processes and technologies
R&D Lab
R&D Lab with scientist guided by a doctorate in Organic chemistry with rich experience
1 mg to multi-tone level
We are capable enough to manufacture from 1 mg to multi-tone levels with multi step reactions.
